“Molecular Mechanisms of FDA-Approved Drugs for the Treatment of Alzheimer’s Disease: A Comprehensive Review”. 2025. Molecular Medicine Communications 5 (1): 17-28. https://doi.org/10.55627/mmc.005.01.01795.